0000899243-15-004962.txt : 20150917
0000899243-15-004962.hdr.sgml : 20150917
20150917173056
ACCESSION NUMBER: 0000899243-15-004962
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150916
FILED AS OF DATE: 20150917
DATE AS OF CHANGE: 20150917
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENXBIO Inc.
CENTRAL INDEX KEY: 0001590877
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9712 MEDICAL CENTER DRIVE
STREET 2: SUITE 100
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 240-552-8181
MAIL ADDRESS:
STREET 1: 9712 MEDICAL CENTER DRIVE
STREET 2: SUITE 100
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: REGENXBIO, Inc.
DATE OF NAME CHANGE: 20150116
FORMER COMPANY:
FORMER CONFORMED NAME: ReGenX Biosciences, LLC
DATE OF NAME CHANGE: 20131101
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Samuels Camille D
CENTRAL INDEX KEY: 0001354034
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37553
FILM NUMBER: 151113441
MAIL ADDRESS:
STREET 1: 2463 JACKSON ST.
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94115
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-09-16
0
0001590877
REGENXBIO Inc.
RGNX
0001354034
Samuels Camille D
C/O REGENXBIO INC.
9712 MEDICAL CENTER DRIVE, SUITE 100
ROCKVILLE
MD
20850
1
0
0
0
Stock Option (Right to Buy)
22.00
2015-09-16
4
A
0
25000
0.00
A
2025-09-16
Common Stock
25000
25000
D
The option will vest in equal monthly installments over the 12 months following September 16, 2015, with immediate full vesting in the event of a change in control.
Under an agreement between the reporting person and VR Management, LLC (the "Management Company"), the reporting person is deemed to hold the reported securities for the sole benefit of the Management Company. The Management Company may be deemed the direct beneficial owner of the reported securities, and the reporting person may be deemed the indirect beneficial owner of the reported securities through her interest in the Management Company. The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.
/s/ Camille Samuels
2015-09-16